This inventor holds 1 USPTO granted patent. Top assignee: Biogen Idec Ma Inc.. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: John DeLuca: Innovator in Multiple Sclerosis Treatment
Introduction
John DeLuca is a notable inventor based in Rockaway, NJ (US). He has made significant contributions to the field of medical technology, particularly in the evaluation and treatment of multiple sclerosis. His innovative work has the potential to improve the lives of many individuals affected by this condition.
Latest Patents
John DeLuca holds 1 patent for his invention titled "Cognitive composite parameters and uses thereof for evaluating multiple sclerosis." This patent encompasses methods, systems, and kits designed for the identification, assessment, and treatment of subjects diagnosed with multiple sclerosis. His work in this area reflects a deep understanding of the complexities involved in managing this neurological disorder.
Career Highlights
DeLuca is currently associated with Biogen Idec Ma Inc., a leading biotechnology company focused on developing therapies for neurological diseases. His role at Biogen Idec Ma Inc. allows him to collaborate with other experts in the field and contribute to groundbreaking research and development efforts.
Collaborations
Throughout his career, John DeLuca has worked alongside esteemed colleagues such as Diego Cadavid and David Erlanger. These collaborations have fostered an environment of innovation and have led to advancements in the understanding and treatment of multiple sclerosis.
Conclusion
John DeLuca's contributions to the field of multiple sclerosis treatment exemplify the impact of innovative thinking in medical technology. His patent and ongoing work at Biogen Idec Ma Inc. highlight the importance of research and collaboration in addressing complex health challenges.